RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
JOURNAL OF CLINICAL ONCOLOGY
Collezione AO Ordine Mauriziano

Items : 31

A multicenter, retrospective study on impact of immunotherapy in urothelial carcinoma with bone metastases (Meet-Uro01 Study) in Journal of Clinical Oncology

2021
AO Ordine Mauriziano

Giannatempo P; Marandino L; Raggi D; Pierantoni F; Maruzzo M; Lipari H; Banna GL; De Giorgi U; Naglieri E; Buti S; Stellato M; Vignani F; Roviello G; Veccia A; Losanno T; Mucciarini C; Pignata S; Necchi A; Di Maio M;

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study in Journal of Clinical Oncology

2021
AO Ordine Mauriziano
ASL VCO
ASL Cuneo 1

King M; Azevedo C; Jonas E; Kloppers C; Srishankar S; Jayarajah U; Ravindrakumar S; Rodrigo VS; Sait M; Di Somma A; Bigay K; Boeck MA; O'Donnell R; Garcia-Loarte Gomez E; Garcia-Moreno Nisa F; Sosa MV; Gutiérrez Fernández AI; Marçal A; Marques R; Martins D; Melo A; Tenreiro N; Vaz Pereira R; Vieira B; Almeida JI; Correia de Sá T; Costa MJMA; Machado D; Akilli H; et alii...

Long-lasting, irreversible and lateonset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis in Journal of Clinical Oncology

2020
AO Ordine Mauriziano

Ghisoni E; Wicky AM; Latifyan S; Alfonso NNM; Özdemir BC; Cuendet MA; Imbimbo M; Marandino L; Delyon J; Gerard CL; Tavazzi E; Gatta R; Valabrega G; Aglietta M; Obeid M; Coukos G; Peters S; Di Maio M; Bouchaab H; Michielin O;

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: Retrospective analysis of clinical outcomes in Journal of Clinical Oncology

2020
AO Ordine Mauriziano
ASL Biella

Giannone G; Scotto G; De Giorgi U; Farolfi A; Katsaros D; Borella F; Ferrero A; Villa M; Tuninetti V; Ghisoni E; Turinetto M; Zavallone L; Aglietta M; Pasini B; Di Maio M; Valabrega G;

FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable metastatic colorectal cancer (mCRC): A meta-analysis of individual patient data (IPD) from five randomized trials in Journal of Clinical Oncology

2020
AO Ordine Mauriziano

Cremolini C; Antoniotti C; Stein A; Bendell JC; Gruenberger T; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll H-J; Di Maio M;

Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts in Journal of Clinical Oncology

2020
AO Ordine Mauriziano

Fontana E; Zichi C; Smyth EC; Mauer ME; Roedel C; Fokas E; Hofheinz RD; Arnold D; Schmoll H-J; Van Cutsem E; Haustermans K; Stein A; Gerard J-P; Conroy T; Jouffroy-Zeller C; Moehler MH; Lordick F; Ben-Aharon I; Di Maio M;

Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project (proFFiT) in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Bryce J; Riva S; Di Maio M; Efficace F; Frontini L; Gallo C; Giannarelli D; Montesarchio V; De Lorenzo F; Del Campo L; Iannelli E; Traclò F; Gitto L; Jommi C; Vaccaro CM; Gimigliano A; Sparavigna L; Perrone F;

Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Buono G; Fabi A; Del Mastro L; Cannita K; La Verde NM; Ardito R; Riccardi F; Montemurro F; Cazzaniga ME; Garrone O; Zambelli A; Conte B; Caputo R; Cianniello D; Bonotto M; Bartoletti M; Parola S; De Placido S; Di Maio M; Arpino G;

Prognostic score for second or further line immunotherapy in advanced non-small cell lung cancer (aNSCLC): An external validation in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Prelaj A; Russo GL; Proto C; Signorelli D; Ferrara R; Galli G; De Toma A; Randon G; Zilembo N; Trevisan B; Montrone M; Longo V; Pesola F; Varesano N; Del Bene G; Pizzutilo P; Galetta D; Garassino MC; Di Maio M; Catino A;

Host metabolic factors and prognosis in patients treated with immune checkpoint inhibitors for advanced malignancies in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Biello F; Audisio M; Genestroni S; Borra G; D'Avanzo F; Lacidogna G; Sponghini AP; Rondonotti D; Forti L; Vignani F; Adesi FB; Di Maio M; Sica A; Gennari A;

Chemotherapy in combination with immune checkpoint inhibitors for the first-line treatment of patients with advanced non-small cell lung cancer: A systematic review and literature-based metaanalysis in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Addeo A; Banna GL; Metro G; Di Maio M;

Quality-of-life (QoL) assessment and reporting in prostate cancer: A systematic review of phase III trials published between 2012 and 2016 in Journal of Clinical Oncology

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; ButtIgliero C; Tucci M; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;

Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open label, registration directed phase II study in Journal of Clinical Oncology

2019
AO Ordine Mauriziano

Reeves JA; Leslie LA; Chavez JC; Ghia P; Tarella C; Burke JM; Sharman JP; Kolibaba K; O'Connor OA; Ghosh N; Patten P; Fowler NH; Samaniego F; Jurczak W; Miskin HP; Sportelli P; Weiss MS; Cheah C; Zinzani PL; Lech-Maranda E;

Biases in assessment and reporting of health-related quality of life (QoL): A systematic review of oncology randomized phase III trials published between 2012 and 2016 in Journal of Clinical Oncology

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;

Bevacizumab (B) + bi-weekly capecitabine (C) and oxaliplatin (O) (XELOX2) or FOLFOX4 in first-line treatment of metastatic colorectal cancer (mCRC): Final results of a multicenter randomized phase II trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM protocol 2802) in Journal of Clinical Oncology

2018
AO Ordine Mauriziano

Maiello E; Di Maggio G; Cordio SS; Cinieri S; Giuliani F; Pisconti S; Rinaldi A; Febbraro A; Pia Latiano T; Aieta M; Rizzi D; Di Maio M; Colucci G; Bordonaro R;

Moving from the CLEOPATRA study to real life: Results from the G.O.N.O. SUPER trial in Journal of Clinical Oncology

2018
ASL Asti
AOU Città della Salute di Torino
AO Ordine Mauriziano

Garrone O; Giarratano T; Saggia C; Bertolini I; Beano A; Blondeaux E; Riva F; D'Onofrio L; Merlini L; Coltelli L; La Verde NM; Vandone AM; Milani A; Collovà E; Ardito R; Airoldi M; De Conciliis E; Blasi L; Di Maio M; Merlano MC;

Oncological benefit of parenchyma-preserving hepatectomy for colorectal liver metastasis in Journal of Clinical Oncology

2016
AO Ordine Mauriziano

Hosokawa I; Allard MA; Nitta H; Lapointe RW; Mirza D; Nuzzo G; Barroso E; Kaiser G; Hubert C; Capussotti L; Poston GJ; Popescu I; Lopezben S; Jzermans JNMI; Ouellet J-F; Salizzoni M; Oreilly D; Skipenko O; Adam R; Hépato-Biliaire C;

Assessment of prognostic factors in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA) after docetaxel (DOC) in Journal of Clinical Oncology

2016
AO Ordine Mauriziano

Cavaliere C; Caffo O; Ortega C; D'aniello C; Di Napoli M; Cecere SC; Della Pepa C; Crispo A; Maines F; Ruatta F; Iovane G; Montella M; Pignata S; Facchini G;

Sequential administration of new agents (NAs) after docetaxel (DOC) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Impact of disease control (DC) duration in second line on the subsequent line outcomes in Journal of Clinical Oncology

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Maines F; De Giorgi U; Facchini G; Fratino L; Gasparro D; Alesini D; Basso U; Tucci M; Ortega C; Scagliarini S; Verderame F; Barni S; D'Angelo A; Vicario G; Donini M; Carrozza F; Sava T; Sirotova Z; Santini D; Caffo O;

Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor to predict overall survival in Journal of Clinical Oncology

2016
AO Ordine Mauriziano

Cavaliere C; Caffo O; Ortega C; D'aniello C; Cecere SC; Di Napoli M; Della Pepa C; Crispo A; Maines F; Ruatta F; Iovane G; Montella M; Pignata S; Facchini G;

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) after a long-term disease control (LTDC) with abiraterone acetate (AA) or enzalutamide (ENZ) post docetaxel (DOC): Preliminary results from a multicenter Italian study in Journal of Clinical Oncology

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Veccia A; De Giorgi U; Facchini G; Fratino L; Gasparro D; Alesini D; Basso U; Tucci M; Ortega C; Scagliarini S; Verderame F; Lo Re G; Procopio G; Sabbatini R; Campadelli E; Zucali PA; Morelli F; Sartori D; Conteduca V; Caffo O;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and secondary CNS involvement: Final results of a multicenter phase II trial in Journal of Clinical Oncology

2015
AO Ordine Mauriziano

Ferreri AJM; Donadoni G; Cabras MG; Patti C; Mian M; Zambello R; Tarella C; Di Nicola M; D'Arco AM; Doa G; Bruno-Ventre M; Assanelli A; Foppoli M; Citterio G; Fanni A; Mulè A; Caligaris-Cappio F; Ciceri F;

Long-term results of the phase III GITMO/FIL trial of CHOP-R versus R-HDS plus autograft in high-risk follicular lymphoma (FL) at diagnosis in Journal of Clinical Oncology

2014
AO Ordine Mauriziano

Magni M; Ladetto M; Gueli A; Passera R; Bruna R; Corradini P; Zoli V; Perrone T; Stelitano C; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Tarella C;

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial in Journal of Clinical Oncology

2014
AO Ordine Mauriziano

Caligaris-Cappio F; Ciceri F; Foppoli M; Fanni A; Doa G; Mulè A; Tarella C; Di Nicola MA; D'Arco A; Ventre MB; Mian M; Zambello R; Cabras MG; Patti C; Ferreri AJM; Donadoni G;

Long-term results of autologous hematopoietic stem-cell transplantation after high-dose90Y-ibritumomab tiuxetan for patients with poor-risk non-Hodgkin lymphoma not eligible for high-dose BEAM in Journal of Clinical Oncology

2013
AO Ordine Mauriziano

Gianni AM; Bombardieri E; Cox MC; Chiesa C; Carlo-Stella C; Ruella M; Viviani S; Matteucci P; Tarella C; Di Nicola M; Testi A; Magni M; Maccauro M; Passera R; Seregni E; Guidetti A; Devizzi L;

Postoperative nomogram for predicting survival after resection for intrahepatic cholangiocarcinoma in Journal of Clinical Oncology

2013
AO Ordine Mauriziano

Ribero D; Rosso S; Pinna AD; Nuzzo G; Guglielmi A; Aldrighetti L; Leone F; Aglietta M; Giulini SM; Gerunda GE; Tomatis M; Berloco P; Calise F; Opocher E; Gruttadauria S; Torzilli G; Capussotti L;

Clinical outcome (CO) and predictive factors (PRE) evaluation of young ( 60 years) castration-resistant prostate cancer (CRPC) patients, treated with docetaxel (DOC): Preliminary results of an Italian multicenter retrospective study (CYCLOP study) in Journal of Clinical Oncology

2013
AO Ordine Mauriziano

Caffo O; Ortega C; Di Lorenzo G; Russa FL; Burgio SL; Messina C; Facchini G; Iacovelli R; Lodde M; Morelli F; Massari F; Procopio G; Zustovich F; Re GL; Pegoraro C; Gamucci T; Pappagallo GL; Veccia A; Maines F; Galligioni E;

Adjuvant chemotherapy following curative intent hepatectomy for intrahepatic cholangiocarcinoma: Results from a multi-institutional analysis of 575 patients in Journal of Clinical Oncology

2012
AO Ordine Mauriziano

Ribero D; Pinna AD; Nuzzo G; Guglielmi A; Aldrighetti L; Giulini SM; Gerunda GE; Ponti A; Tomatis M; Leone F; Aglietta M; Berloco P; Calise F; Opocher E; Gruttadauria S; Torzilli G; Capussotti L;

Evaluation of cost-effectiveness of early KRAS testing in high-risk recurrence colorectal cancer patients in Italy in Journal of Clinical Oncology

2012
AO Ordine Mauriziano

Pinto C; Barone C; Normanno N; Cognetti F; Falcone A; Capussotti L; Mantovani L;

Modeling fecal incontinence symptoms 6 years after high-dose radiation for prostate cancer: Clinical and dosimetric predictors in Journal of Clinical Oncology

2012
AO Ordine Mauriziano

Fellin G; Rancati T; Fiorino C; Vavassori V; Cagna E; Mauro F; Malinverni G; Valdagni R;

Phase II study of 153-samarium-EDTMP followed by haematopoietic stem cell for patients with osteosarcoma with bone metastasis in Journal of Clinical Oncology

2011
AO Ordine Mauriziano

Massimo B; Grignani G; Giostra A; Pagano M; Ferrari S; Elia BO; Carnevale-Scianca F; Aglietta M; Pellerito RE; Fagioli F;